Alyeska Investment Group

Alyeska Investment Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Alyeska Investment Group’s Portfolio ADAP Stock Details ADAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell
2020 Q2	$626K	Buy
2015 Q4	–	Sell
2015 Q3	$1.42M	Sell
2015 Q2	$2.38M	Buy